EyePoint Pharmaceuticals Announces Updated Positive Interim Safety and Efficacy Data from Ongoing Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMDPRNewsWire • 02/12/22
EyePoint Pharmaceuticals Announces 2022 Clinical Plans and Highlights Recent Corporate and Clinical AchievementsGlobeNewsWire • 01/10/22
EyePoint Pharmaceuticals Appoints Michael C. Pine as Chief Corporate Development and Strategy OfficerGlobeNewsWire • 01/10/22
EyePoint Pharmaceuticals and Harrow Health's ImprimisRx Announce Expanded U.S. Commercial Alliance for DEXYCU®GlobeNewsWire • 12/07/21
EYPT Stock: The Clinical Trial News That Has EyePoint Pharma Investors Seeing Green TodayInvestorPlace • 11/15/21
EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMDPRNewsWire • 11/13/21
EyePoint Pharmaceuticals to Host Conference Call Highlighting Interim Phase 1 Clinical Data from Ongoing DAVIO Trial of EYP-1901 for Wet AMDGlobeNewsWire • 11/05/21
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/03/21
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/03/21
EyePoint Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate DevelopmentsGlobeNewsWire • 11/03/21
EyePoint Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 3, 2021GlobeNewsWire • 10/27/21
EyePoint Pharmaceuticals Presents Preliminary Safety Data from Phase 1 DAVIO Trial and YUTIQ® CALM Registry Study at American Society of Retina Specialists (ASRS) 39th Annual MeetingGlobeNewsWire • 10/12/21
EyePoint Sets its Sights on Developing Treatments Improving the Lives of Eye Disease SufferersBenzinga • 09/30/21
EyePoint Pharmaceuticals to Present Data at the American Academy of Ophthalmology (AAO) 2021 Annual MeetingGlobeNewsWire • 09/17/21
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
EyePoint Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate DevelopmentsGlobeNewsWire • 08/04/21
EyePoint Pharmaceuticals Announces Renowned Scientists to Join New Executive Scientific Advisory BoardGlobeNewsWire • 08/02/21